Randomized, placebo-controlled study of Lamifiban with thrombolytic therapy for the treatment of acute myocardial infarction: Rationale and design for the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) study
- David J. Moliterno
- , Robert A. Harrington
- , Robert M. Califf
- , Hans J. Rapold
- , Eric J. Topol
Research output: Contribution to journal › Article › peer-review
23
Scopus
citations